Carlsmed, Inc. (CARL) stock
CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30118% above fair value
$17.74+0.39 (+2.25%)
Close on Nov 17, 2026Market cap $484.35MP/E –Yield –
Carlsmed gross margin
Gross margin is gross profit as a percentage of revenue.
Carlsmed's gross margin for the twelve months ending Jun 30, 2026 was 76.6%. For fiscal 2025 it was 75.3%, against 73.8% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 75.3% | +1.5 |
| FY2024 | Dec 31, 2024 | 73.8% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 76.8% | +3.4 |
| Q1 FY2026 | Mar 31, 2026 | 77.1% | +2.2 |
| Q4 FY2025 | Dec 31, 2025 | 76.5% | +1.9 |
| Q3 FY2025 | Sep 30, 2025 | 75.9% | +3.1 |
| Q2 FY2025 | Jun 30, 2025 | 73.4% | −1.6 |
| Q1 FY2025 | Mar 31, 2025 | 74.9% | – |
| Q4 FY2024 | Dec 31, 2024 | 74.7% | – |
| Q3 FY2024 | Sep 30, 2024 | 72.8% | – |
| Q2 FY2024 | Jun 30, 2024 | 75.0% | – |
See a number that looks wrong?